Media release
From:
JAMA
Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
What The Study Did: Survey results indicate concerns regarding the safety of the human papillomavirus (HPV) vaccine are increasing among hesitant parents despite consistent evidence of the vaccine’s safety from trials and the reporting of adverse events.
Attachments
Note: Not all attachments are visible to the general public.
Research URLs will go live after the embargo ends.
Research
JAMA, Web page
The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Organisation/s:
UTHealth School of Public Health, USA
Funder:
This study was supported by the National Institute on Minority Health and Health Disparities
under award number K01MD016440 and the National Cancer Institute of the National Institutes of Health under
award number R01CA232888.